With a growing emphasis on value-based reimbursement, developing quality indicators for infectious diseases has gained attention. Quality indicators for fever of unknown origin and inflammation of unknown origin are lacking. An assembled group of international experts developed 12 quality measures for these conditions, which could be validated with additional study.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10853001 | PMC |
http://dx.doi.org/10.1093/ofid/ofad671 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!